Publication | Closed Access

Shikonin exerts anti-inflammatory effects in a murine model of lipopolysaccharide-induced acute lung injury by inhibiting the nuclear factor-kappaB signaling pathway

Acute Lung InjuryInflammationCytokineAnti-inflammatoryInflammatory Lung DiseaseLung InflammationMedicineMurine ModelImmunologyCell DeathChronic InflammationAnti-inflammatory EffectsPulmonary PharmacologyPharmacologyCell SignalingOxidative Stress